Hosted by Mary Ann Liebert, organized by BioConferences and Program Chair Dr. David B. Weiner, PhD. – University of Pennsylvania, USA
March 2 - 4, 2010
Sheraton New Orleans Hotel
New Orleans, LA
Agenda to date:
MARCH 2, 2010
Registration Opens: 9am - 5pm
Morning Sessions
Welcome Address from the Program Chairman: Enhancing DNA Vaccine Immunity in Vivo
David B. Weiner, PhD — University of Pennsylvania
Lunch Break
The Future of Vaccines from an Industry Perspective
John Shiver, PhD — Merck
Human Immune Responses to Vaccination
Mark Slifka, PhD — OSHU
Preclinical and Clinical Studies of DNA Vaccines for Biodefense
Connie Schmaljohn, PhD — USAMRIID
George Kemble — Medimmune
Break
Approaches to Influenza
Jukka Hartikka, PhD — Vical
SynCon™ DNA Vaccines for Infectious Diseases
NiranJan Sardesai, PhD — Inovio Biomedical Corporation
The Strengths and Weaknesses of Inducing Mismatched Immunity to Expand Cross-Protection Against Influenza Viruses
Gary Kobinger, PhD — PHAC
5:30 - 7:30pm: Cocktail Social Hour in Exhibits Poster Area
MARCH 3, 2010
RV 144 ALVAC-HIV/AIDSVAX Study: Implications for HIV Vaccine Development
Col. Nelson Michael, MD, PhD — Walter Reed Army Institute of Research, US Military HIV Research Program (MHRP)
Technologies for Improved Vaccines
Jeffrey Ulmer, PhD — Novartis Vaccines & Diagnostics
Ron Veazey — Tulane
Break
What is a Protective T Cell Response
Michael Betts, PhD — University of Pennsylvania School of Medicine
Heterologous Prime-Boost HIV Vaccines
Shan Lu, ME, PhD — University of Massachusetts Medical School
Clinical Experiences of HIV Genetic Vaccines
Britta Wahren, MD, PhD — Karolinska Institute
Studies in Preclinical Macaque Models of DNA/MVA Vaccines
Harriet L. Robinson, PhD — Geovax Inc.
Lunch Break
Optimization of DNA and Combination Vaccines in Macaques
George Pavlakis, MD, PhD — NCI
Prime-boost Vaccination Regimens to Elicit Optimal Immune Responses
Mike Egan, PhD — Profectus BioScience, Inc.
In Vivo Electroporation Enhances the Immunogenicity of ADVAX, a DNA-based HIV-1 Vaccine Candidate, in Healthy Volunteers
Sandhya Vasan, MD — Aaron Diamond AIDS Research Center
Genomic Signatures of DNA Vaccines
Jean Boyer, PhD — University of Pennsylvania
Immunogenicity of VRC DNA Vaccines for HIV, WNV and Influenza
Julie Ledgerwood — VRC
Break
Selected Abstract Talks
Panel Discussion:
Stanley Plotkin, Joseph Kim, John Shiver, Andrew Murdin, Robert Menardi, Joe Lovett
Dinner Speaker:
Special Invited Speaker: Correlates of Protection from Infection
Stanley Plotkin, MD — Vaxconsult LLC
Presentation of Maurice Hilleman Award - John Shiver
Presentation of Richard Ginsberg Award - David Weiner
5:30 - 7:00pm: Cocktail Social Hour in Exhibits Poster Area
7:00pm: Gala Dinner in Banquet Hall
MARCH 4, 2010
Regulatory Gene Networks
Bin Wang, PhD — China Agricultural University
Therapeutic HPV DNA Vaccine Development
T.C. Wu, MD, PhD — The Johns Hopkins Medical Institutions
Approaches to HCV DNA Vaccines
Matti Sällberg, PhD — Tripep Pharma
Break
Antigen Specific Immunity after CTLA-4 Blockade: Investigation The Role of Prior Vaccination
Jianda Yuan, MD, PhD — Tripep Pharma
Robert Menardi — Merial
DNA Vaccine Trials in Pigs to Evaluate Potential Medical and Veterinary Use
Eiji Kobayashi, MD, PhD — Jichi Medical School
Microbial Genes to Awaken Immunity Against Cancer Antigens
Freda Stevenson, PhD — University of Southampton, School of Medicine
Lunch Break
DNA Vaccine Based on Cancer-Testis Antigen, BORIS and IL21 Molecular Adjuvant in Extremely Effective For Treatment of Metastatic Disease
Michael Agadjanian — The Institute for Molecular Medicine
Comparative Performance Evaluation of Electroporation Mediated DNA Immunization Versus Conventional Vaccine Approaches
Brian Livingston — Ichor Medical Systems
Immunization with Drug-Resistant HIV-1 Enzyme Genes
Maria Isaguliants — Karolinska Institute
Conserved Elements Vaccine for HIV-1 Gagp24 is Immunogenic in Mice and Macaques
James Mullins, PhD — University of Washington
Induction of Cross-clade Neutralizing Antibodies with a Prime/Boost Vaccine Strategy Focused on a Neutralizing Epitope
Susan Zolla-Pazner,PhD — NYU Medical School
Selected Abstract Talks
Break
Transformative Technologies in the Vaccine Area - How Will We Know?
David Kaslow, MD — Merck
Recent Advances in Malaria Vaccine Development
Ashley Birkett, PhD — PATH MVI
Recombinant DNA Considerations in the EU - What Lies Ahead for Developers?
Ruxandra Draghia-Akli, MD, PhD — European Commission
DNA Vaccines: A View from Both Sides of the Fence and Both Sides of the Pond - Panel Discussion
David Kaslow, Ruxandra Draghlia-Akli, Ashley Birkett, Connie Schmaljohn, Alan Bernstein